| Literature DB >> 15811184 |
Trish Mannes1, Katy Emmett, Alan Willmore, Tim Churches, Vicky Sheppeard, Jill Kaldor.
Abstract
BACKGROUND: We conducted a retrospective study to determine if potential past exposure to dioxin had resulted in increased incidence of cancer in people living near a former manufacturing plant in New South Wales, Australia. During operation, from 1928 to 1970, by-products of the manufacturing process, including dioxin and other chemical waste, were dumped into wetlands and mangroves, discharged into a nearby bay and used to reclaim land along the foreshore, leaving a legacy of significant dioxin contamination.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15811184 PMCID: PMC1087492 DOI: 10.1186/1471-2458-5-34
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Number (and percentage) of cases of selected types of cancers occurring in the Rhodes study area compared with New South Wales (based on 30 year counts).
| Percentage | ||
| Lung and Bronchus Carcinomas | 143 | 12.93% |
| Haematopoietic | 85 | 7.69% |
| Leukaemia | 31 | |
| Non-Hodgkin's Lymphoma | 40 | |
| Multiple Myeloma | 9 | |
| Prostate | 116 | 10.49% |
| Breast cancer | 142 | 12.84% |
| Colorectal | 153 | 13.83% |
| Gynaecological | 61 | 5.52% |
| Urothelial | 35 | 3.16% |
| Melanoma of the skin | 94 | 8.50% |
| Site unknown | 57 | 5.15% |
Definitions:
Colorectal: Cancers of colon, rectum and anus (ICD-10 C18-C21)
Haematopoietic: Lymphoma, leukaemia, multiple myeloma (ICD-10 C81-C96)
Gynaecological: Uterus, ovary, other female genital organs (ICD-10 C51-C58)
Urothelial: Urinary tract excluding body of kidney (ICD-10 C65-C68)
SIR and SMR for Rhodes study area compared with New South Wales and compared with Ryde and Concord SLAs for all cancers.
| 30 years | 1106/524 | New South Wales | 87. 6# | (82.5, 92. 9) | 88.7# | (81.3, 96.7) |
| 30 years | 1106/524 | Concord and Ryde SLAs | 90.5# | (85.2, 96.0) | 92.9 | (85.1, 101.2) |
| 25 years | 922/530 | New South Wales | 91.2# | (85.4, 97.2) | 93.5 | (85.2, 102.3) |
Notes:
SLA = Statistical Local Area
SIR = Standardised Incidence Ratio
SMR = Standardised Mortality Ratio
# Statistically significantly lower than the comparison area
* Statistically significantly higher than the comparison area
SIR and SMR for each census collector district in the Rhodes study area compared with New South Wales for all cancers (based on 25 year counts).
| 1410101 | 76 | 200 | 113.6 | 90.3–141.0 | 119.0 | 85.4–161.4 |
| 1410102 | 34 | 985 | 149.0* | 108.7–199.3 | 113.8 | 66.3–182.3 |
| 1380508 | 14 | 1014 | 49.0# | 26.8–82.3 | 52.3 | 19.2–113.9 |
| 1380507 | 13 | 1190 | 48.5# | 25.0–84.6 | 21.7# | 2.6–78.2 |
| 1380503 | 35 | 1241 | 96.3 | 67.8–132.7 | 111.2 | 68.0–171.8 |
| 1380509 | 58 | 1248 | 184.1* | 128.3–256.1 | 128.2 | 61.5–235.8 |
| 1380501 | 76 | 1250 | 76.3# | 57.8–98.9 | 66.8# | 42.8–99.3 |
| 1410103 | 78 | 1302 | 91.3 | 74.0–111.5 | 81.9 | 58.8–111.1 |
| 1381207 | 61 | 1415 | 80.1 | 61.1–103.1 | 79.5 | 54.0–112.9 |
| 1381209 | 76 | 1428 | 102.8 | 81.9–127.4 | 137.4* | 102.3–180.6 |
| 1380505 | 25 | 1527 | 94.3 | 63.2–135.5 | 107.7 | 58.9–180.6 |
| 1380504 | 58 | 1530 | 83.0 | 63.5–106.6 | 93.1 | 66.2–127.2 |
| 1380510 | 51 | 1561 | 71.8# | 51.3–97.8 | 79.9 | 52.2–117.1 |
| 1381211 | 38 | 1576 | 101.3 | 72.4–138.0 | 83.5 | 46.7–137.7 |
| 1380506 | 22 | 1633 | 100.9 | 63.2–152.8 | 116.7 | 58.3–208.8 |
| 1381210 | 11 | 1638 | 56.3 | 28.1–100.6 | 88.3 | 38.1–174.0 |
| 1410104 | 8 | 1682 | 84.5 | 56.2–122.2 | 93.4 | 52.3–154.1 |
| 1380502 | 34 | 1717 | 105.8 | 80.2–137.1 | 109.1 | 72.5–157.6 |
| 1410105 | 71 | 1874 | 89.6 | 68.8–114.6 | 99.0 | 68.6–138.3 |
| 1410301 | 83 | 1935 | 81.1 | 63.6–102.0 | 82.6 | 58.2–113.9 |
Notes:
SLA = Statistical Local Area
SIR = Standardised Incidence Ratio
SMR = Standardised Mortality Ratio
+ Distance from site = distance between the centroid of the collector district from the centre of the former Union Carbide site
# Statistically significantly lower than the comparison area
* Statistically significantly higher than the comparison area
SIR and SMR for Rhodes study area compared with New South Wales and compared with Ryde and Concord SLAs for lung and bronchus carcinoma and haematopoietic cancers (based on 30 year counts)
| Lung and Bronchus Carcinomas | 143/121 | NSW | 105.5 | 88.9–124.2 | 107.1 | 88.9–128.0 |
| Haematopoietic neoplasms | 85/46 | NSW | 80.6# | 64.3–99.6 | 80.8 | 59.2–107.8 |
| Lung and Bronchus Carcinomas | 143/121 | Concord & Ryde SLAs | 115.7 | 97.5–136.3 | 116.2 | 96.4–138.8 |
| Haematopoietic neoplasms | 85/46 | Concord & Ryde SLAs | 75.0# | 59.9–92.7 | 78.3 | 57.3–104.4 |
Notes:
SLA = Statistical Local Area
SIR = Standardised Incidence Ratio
SMR = Standardised Mortality Ratio
# Statistically significantly lower than the comparison area
* Statistically significantly higher than the comparison area